{"product_id":"pt141-pen","title":"PT-141 Pen","description":"\u003cp data-start=\"257\" data-end=\"694\"\u003e\u003cstrong data-start=\"257\" data-end=\"267\"\u003ePT‑141\u003c\/strong\u003e, also known as \u003cstrong data-start=\"283\" data-end=\"300\"\u003eBremelanotide\u003c\/strong\u003e, is a synthetic peptide from the melanocortin family. Unlike traditional sexual enhancement approaches that act on the vascular system, PT‑141 works \u003cstrong data-start=\"450\" data-end=\"492\"\u003edirectly on the central nervous system\u003c\/strong\u003e to influence pathways involved in \u003cstrong data-start=\"527\" data-end=\"556\"\u003esexual desire and arousal\u003c\/strong\u003e. This mechanism makes it a unique candidate in research focused on \u003cstrong data-start=\"624\" data-end=\"655\"\u003elibido and intimacy support\u003c\/strong\u003e. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"696\" data-end=\"699\"\u003e\n\u003cp data-start=\"701\" data-end=\"723\"\u003e\u003cstrong\u003e⚗️ Product Features\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"725\" data-end=\"995\"\u003e\n\u003cli data-start=\"725\" data-end=\"769\"\u003e\n\u003cp data-start=\"727\" data-end=\"769\"\u003e🧪 Melanocortin receptor agonist peptide\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"770\" data-end=\"834\"\u003e\n\u003cp data-start=\"772\" data-end=\"834\"\u003e🧠 Targets central nervous system pathways related to desire\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"835\" data-end=\"870\"\u003e\n\u003cp data-start=\"837\" data-end=\"870\"\u003e✅ ≥98 % purity verified by HPLC\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"871\" data-end=\"933\"\u003e\n\u003cp data-start=\"873\" data-end=\"933\"\u003e📄 Batch‑specific Certificates of Analysis (COAs) included\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"934\" data-end=\"995\"\u003e\n\u003cp data-start=\"936\" data-end=\"995\"\u003e💧 Sterile, lyophilized peptide for research applications\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"997\" data-end=\"1000\"\u003e\n\u003cp data-start=\"1002\" data-end=\"1044\"\u003e\u003cstrong\u003e🔬 Human‑Relevant Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"1046\" data-end=\"1087\"\u003e\u003cstrong\u003e🔥 Enhances Sexual Desire \u0026amp; Arousal\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"1088\" data-end=\"1478\"\u003eClinical Phase III trials have demonstrated that \u003cstrong data-start=\"1137\" data-end=\"1198\"\u003ebremelanotide significantly improves sexual desire scores\u003c\/strong\u003e and \u003cstrong data-start=\"1203\" data-end=\"1257\"\u003ereduces distress associated with low sexual desire\u003c\/strong\u003e in premenopausal women with hypoactive sexual desire disorder (HSDD) compared with placebo, based on validated measures such as the Female Sexual Function Index (FSFI) desire domain. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"1480\" data-end=\"1649\"\u003e🔗 \u003ca data-start=\"1483\" data-end=\"1524\" rel=\"noopener\" class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31599840\/?utm_source=chatgpt.com\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/31599840\/\u003c\/a\u003e— Bremelanotide increases sexual desire and reduces distress in HSDD Phase III trials. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"1651\" data-end=\"1654\"\u003e\n\u003cp data-start=\"1656\" data-end=\"1679\"\u003e\u003cstrong\u003e🧾 Mechanism Summary\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"1681\" data-end=\"1942\"\u003e\n\u003cli data-start=\"1681\" data-end=\"1785\"\u003e\n\u003cp data-start=\"1683\" data-end=\"1785\"\u003e🧠 Central melanocortin receptor (MC4R) agonism influences \u003cstrong data-start=\"1742\" data-end=\"1783\"\u003eneural circuits of desire and arousal\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1786\" data-end=\"1867\"\u003e\n\u003cp data-start=\"1788\" data-end=\"1867\"\u003e📈 Clinically linked to \u003cstrong data-start=\"1812\" data-end=\"1839\"\u003eincreased desire scores\u003c\/strong\u003e in validated human trials\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1868\" data-end=\"1942\"\u003e\n\u003cp data-start=\"1870\" data-end=\"1942\"\u003e🧩 Distinct mechanism from vascular‑targeted sexual enhancement agents\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"2235\" data-end=\"2238\"\u003e\n\u003cp data-start=\"2240\" data-end=\"2280\"\u003e\u003cstrong\u003e❓ Frequently Asked Research Questions\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"2282\" data-end=\"2615\"\u003e\u003cstrong data-start=\"2282\" data-end=\"2329\"\u003eWhat has PT‑141 been studied for in humans?\u003c\/strong\u003e\u003cbr data-start=\"2329\" data-end=\"2332\"\u003ePT‑141 has been studied mainly for \u003cstrong data-start=\"2367\" data-end=\"2445\"\u003eenhancing sexual desire and reducing distress related to low sexual desire\u003c\/strong\u003e in premenopausal women with hypoactive sexual desire disorder, with statistically significant results in clinical Phase III trials.\u003c\/p\u003e","brand":"Limitless Wellness Lab","offers":[{"title":"10mg","offer_id":47663963832558,"sku":null,"price":850.0,"currency_code":"AED","in_stock":true},{"title":"20mg","offer_id":48020429275374,"sku":null,"price":1150.0,"currency_code":"AED","in_stock":true},{"title":"30mg","offer_id":48020429308142,"sku":null,"price":1500.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0697\/5917\/2846\/files\/hf_20260526_095139_92308ce2-ce53-4ac3-a55e-b114414e7d21.png?v=1779789320","url":"https:\/\/syncom.shop\/ar\/products\/pt141-pen","provider":"Limitless Wellness Lab","version":"1.0","type":"link"}